ConductScience.org, home

Trial · NCT05995405

Registered outcomes16

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primary
Incidence (% or proportion) of subjects with at least one episode of clinically significant hypotension with a reasonable possibility that GTX-104/oral nimodipine caused the event, according to the Endpoint Adjudication Committee.
90 daysHypotension events requiring medical treatment
SecondaryTotal number of episodes of clinically significant hypotensionDay 1 - Day 90
SecondaryDuration of episodes of clinically significant hypotensionDay 1 - Day 90Calendar days
SecondaryIncidence and severity of Adverse Events (AEs) based on the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE, Version 5.0).Day 1 - Day 90
SecondaryIncidence of delayed cerebral ischemia (DCI)Day 1 - Day 21
Delayed cerebral ischemia will be evaluated and defined by the following: * For subjects in whom changes in the mGCS and Abbreviated National Institutes of Health Stroke Scale (aNIHSS) are assessable: a decrease of at least 2 points on the mGCS or an increase of at least 2 points on the aNIHSS, lasting for at least 2 hours, where other medical or surgical causes are excluded. The deterioration is measured relative to the best score attained after aneurysm repair. * For subjects in whom the neurologic scales are not assessable: radiological evidence and clinical judgement.
SecondaryUse of rescue therapy for DCIDay 1 - Day 21Rescue therapy is defined as induced hypertension, selective intraarterial infusion of vasodilator drugs or balloon angioplasty.
SecondarySuicidal ideation using the Columbia-Suicide Severity Rating Scale (C-SSRS) score of ≥ 4Day 1 - Day 90
OtherNumber of intensive care unit (ICU) staysDay 1 - Day 90
OtherDuration of intensive care unit (ICU) staysDay 1 - Day 90
OtherDuration (calendar days) of mechanical ventilationDay 1 - Day 90
OtherTherapeutic Intensity Scale (TIS)Day 1 - Day 14
Assessed on a daily basis until Day 14 post-aSAH for the occurrence or use of mechanical ventilation, ICP monitoring, a central venous or arterial line, an external ventricular drain, deep sedation, pharmacological paralysis, and whether or not the patient is comatose for a period of at least 8 hours on that day.
OtherNumber of hospital staysDay 1 - Day 90
OtherDuration of hospital staysDay 1 - Day 90Calendar days
OtherHospital discharge dispositionDay 1 - Day 90Discharge to: (e.g., home, rehabilitation, long-term care)
OtherQuality of Life as measured by EQ-5D-3LDay 30 and Day 90
OtherModified Rankin Scale (mRS)Day 30 and Day 90
0 - No symptoms 1. \- No significant disability despite symptoms; able to carry out all usual duties and activities 2. \- Slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance 3. \- Moderate disability; requiring some help, but able to walk without assistance 4. \- Moderately severe disability; unable to walk and attend to bodily needs without assistance 5. \- Severe disability; bedridden, incontinent and requiring constant nursing care and attention 6. \- Dead

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05995405/registered